Freenome
Backed by
Raised $254M Series E on Feb 15, 2024
Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages.
Director, HRBP
Brisbane, California · Posted on Jul 2, 2025
Manager, Accounting
Brisbane, California · Posted on Jul 2, 2025
Manager, Cost Accounting
Brisbane, California · Posted on Jul 2, 2025
Senior Information Security Analyst II
Remote · Posted on Jul 2, 2025
Staff Business Solutions Engineer
Remote · Posted on Jul 2, 2025
Staff Software Engineer, Infrastructure
Remote · Posted on Jul 2, 2025
Associate Director, Product Management
Brisbane, California · Posted on May 28, 2025
Automation Engineer III
Brisbane, California · Posted on May 28, 2025
Automation Service Engineer III
Brisbane, California · Posted on May 28, 2025
Future Consideration
Brisbane, California · Posted on May 28, 2025
Senior Computational Biologist
Brisbane, California · Posted on May 28, 2025
Senior Director, Market Access
Brisbane, California · Posted on May 28, 2025
Explore similar companies to Freenome
Headlight
Online therapy and mental health services.
Silna
Make care your primary focus.
Tandem Health
Medical notes that write themselves.
Eternal
Longevity care for athletes.
Anterior
Lead your health plan into the future.
Tennr
The intelligent automation platform for healthcare ops.
OpenEvidence
The leading medical information platform.
Collate
Empowering life sciences development.
Optura
AI orchestration platform for healthcare.